Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this appears to be a minor system or formatting update with no changes to the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedLocation blocks were expanded to include additional sites across multiple US states (Arizona, California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Missouri, New York, Ohio, Pennsylvania, Texas, Washington) and Canadian provinces (Ontario, Quebec). The page revision was updated to v3.3.3, with earlier blocks reorganized and the revision tag updated from v3.3.2.SummaryDifference0.9%

- Check79 days agoChange DetectedPublications are described as automatically filled from PubMed with an updated Revision: v3.3.2. The previous note about PubMed publications and Revision: v3.2.0 has been removed.SummaryDifference0.1%

- Check86 days agoChange Detected- Removed the banner notice about government funding and NIH Clinical Center operating status; the page no longer displays that status information.SummaryDifference0.2%

- Check101 days agoChange DetectedThe POLO study page content remains unchanged between the two screenshots. Core sections such as the title, study design, eligibility criteria, outcomes, and listed locations are the same.SummaryDifference0.2%

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.